These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 18472357

  • 1. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E, Berardi F, Natalino F, Moleti ML, Di Rocco A, Enrici RM, Foà R, Martelli M.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1154-60. PubMed ID: 18472357
    [Abstract] [Full Text] [Related]

  • 2. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Mazzarotto R, Boso C, Vianello F, Aversa MS, Chiarion-Sileni V, Trentin L, Zambello R, Muzzio PC, Fiore D, Sotti G.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):823-9. PubMed ID: 17379431
    [Abstract] [Full Text] [Related]

  • 3. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
    Zinzani PL, Martelli M, Bendandi M, De Renzo A, Zaccaria A, Pavone E, Bocchia M, Falini B, Gobbi M, Gherlinzoni F, Stefoni V, Tani M, Tura S.
    Haematologica; 2001 Feb 01; 86(2):187-91. PubMed ID: 11224489
    [Abstract] [Full Text] [Related]

  • 4. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, Gallo E, Ambrosetti A, Tecchio C, Tarella C, Gabbas A, Gallamini A, Gargantini L, Pizzuti M, Fioritoni G, Gottin L, Rossi G, Lazzarino M, Menestrina F, Paulli M, Palestro M, Cabras MG, Di Vito F, Pizzolo G.
    Br J Cancer; 2004 Jan 26; 90(2):372-6. PubMed ID: 14735179
    [Abstract] [Full Text] [Related]

  • 5. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
    Zinzani PL, Martelli M, Bertini M, Gianni AM, Devizzi L, Federico M, Pangalis G, Michels J, Zucca E, Cantonetti M, Cortelazzo S, Wotherspoon A, Ferreri AJ, Zaja F, Lauria F, De Renzo A, Liberati MA, Falini B, Balzarotti M, Calderoni A, Zaccaria A, Gentilini P, Fattori PP, Pavone E, Angelopoulou MK, Alinari L, Brugiatelli M, Di Renzo N, Bonifazi F, Pileri SA, Cavalli F, International Extranodal Lymphoma Study Group (IELSG).
    Haematologica; 2002 Dec 26; 87(12):1258-64. PubMed ID: 12495899
    [Abstract] [Full Text] [Related]

  • 6. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL, Stefoni V, Finolezzi E, Brusamolino E, Cabras MG, Chiappella A, Salvi F, Rossi A, Broccoli A, Martelli M.
    Clin Lymphoma Myeloma; 2009 Oct 26; 9(5):381-5. PubMed ID: 19858058
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A.
    Orv Hetil; 2004 Dec 12; 145(50):2531-7. PubMed ID: 15662753
    [Abstract] [Full Text] [Related]

  • 8. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A, García EL, Fernández R, Gonzalez JL, Neri N, Díaz-Maqueo JC.
    Ann Hematol; 2002 Jul 12; 81(7):368-73. PubMed ID: 12185505
    [Abstract] [Full Text] [Related]

  • 9. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
    Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G.
    N Engl J Med; 1997 May 01; 336(18):1290-7. PubMed ID: 9113932
    [Abstract] [Full Text] [Related]

  • 10. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
    Zinzani PL, Martelli M, Magagnoli M, Zaja F, Storti S, Pavone E, Lauta VM, De Renzo A, Gobbi M, Bocchia M, Ronconi F, Scaramucci L, Gherlinzoni F, Palombi F, Bendandi M, Stefoni V, Anticoli Borza P, Cellini C, Mandelli F, Tura S.
    Haematologica; 1999 Nov 01; 84(11):996-1001. PubMed ID: 10553159
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R, Grillo G, Tedeschi A, Gargantini L, Marenco P, Tresoldi E, Barbarano L, Nosari AM, Morra E.
    Bone Marrow Transplant; 2002 Mar 01; 29(6):473-7. PubMed ID: 11960265
    [Abstract] [Full Text] [Related]

  • 12. International prognostic index-based outcomes for diffuse large B-cell lymphomas.
    Wilder RB, Rodriguez MA, Medeiros LJ, Tucker SL, Ha CS, Romaguera JE, Pro B, Hess MA, Cabanillas F, Cox JD.
    Cancer; 2002 Jun 15; 94(12):3083-8. PubMed ID: 12115338
    [Abstract] [Full Text] [Related]

  • 13. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A.
    Cancer; 2005 Mar 01; 103(5):970-7. PubMed ID: 15666323
    [Abstract] [Full Text] [Related]

  • 14. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T, Tsuchiya K, Nishioka S, Kitahara T, Ohmori K, Homma A, Aoyma H, Shindoh M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):847-52. PubMed ID: 15465202
    [Abstract] [Full Text] [Related]

  • 15. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 16. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N, Eghbali H, Soubeyran P, Trojani M, Richaud P, Bonnel C, Quénel-Tueux N, Hoerni B.
    Bull Cancer; 1997 Jul 01; 84(7):704-8. PubMed ID: 9339196
    [Abstract] [Full Text] [Related]

  • 17. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834
    [Abstract] [Full Text] [Related]

  • 18. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB, Rodriguez MA, Ha CS, Pro B, Hess MA, Cabanillas F, Cox JD.
    Cancer; 2001 Jun 15; 91(12):2440-6. PubMed ID: 11413536
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Karkantaris C, Anargyrou K, Boutsis DE, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):765-81. PubMed ID: 15183480
    [Abstract] [Full Text] [Related]

  • 20. Treatment of diffuse non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisolone and bleomycin (MACOP-B).
    Sawada U, Yamazaki T, Suzuki K, Ashiya M, Satou Y, Hirano H, Tsuboi I, Sakuma A, Kura Y, Kouda K.
    Int J Hematol; 1992 Aug 01; 56(1):59-66. PubMed ID: 1382663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.